| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.4 |